Company page

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. (Ticker: GANX) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $80.2 million, the company is actively engaged in developing treatments for various diseases. Gain Therapeutics aims to leverage its unique approach to drug discovery and development to address unmet medical needs.